We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info . X close

Assisted Reproductive Technology Market: Growth, Size, Share, and Trends

Report Code MD 9335
Published in Mar, 2025, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Assisted Reproductive Technology Market by Technology (In Vitro Fertilization, Artificial Insemination), Type (Instruments (Incubators), Media (Cryopreservation), Supplements, Consumables), Patient Type (Male, Female), End User - Global Forecast to 2030

Overview

The global assisted reproductive technology market, valued at US$4.02 billion in 2024, is forecasted to grow at a robust CAGR of 7.0%, reaching US$4.29 billion in 2025 and an impressive US$6.02 billion by 2030. The assisted reproductive technology market has been segmented by type, technology, patient type, care settings, and region. Increased levels of infertility caused by stress, lifestyle changes, and medical conditions are among the key drivers affecting the assisted reproductive technology (ART) market. The sector has expanded due to technological advancements such as preimplantation genetic testing (PGT), embryo freezing, and enhanced in-vitro fertilization (IVF) techniques that have significantly improved success rates. Industry growth is prevented by ethical and regulatory issues, including legal bans, expensive processes, and the ethical debate over the handling of embryos and surrogacy. Government backing from the state, a change in social perception, and rising public awareness all drive market growth. Improved healthcare infrastructure and greater disposable incomes in the developing world can spur developments in ART therapy.

Assisted Reproductive Technology Market – Global Forecast and Key Opportunities to 2030

Attractive Opportunities in the Assisted Reproductive Technology Market

Asia Pacific

The Asia Pacific region is expected to grow at the highest CAGR of 7.9% during the forecast period owing to the increasing infertility rates, rising awareness of fertility treatments, and improving healthcare infrastructure. Factors such as changing lifestyles, delayed pregnancies, and stress-related fertility issues are driving demand for ART procedures in the region.

Growth in this market is mainly driven by the increasing median age of pregnancy, rising infertility rate, booming fertility industry and volving technological landscape.

High cost of IVF procedures, Social and ethical concerns in developing countries, and elevated risk of complications

The Asia Pacific market is projected to reach USD 2,196.4 million by 2030 during the forecast period.

The high healthcare expenditure, growth opportunities in emerging economies, availability of diverse range of fertility treatment options are expected to offer lucrative growth opportunities for market players.

Global Assisted Reproductive Technology Market Dynamics

DRIVER: Rising Infertility Rate

Around 17.5% of the adult population, roughly 1 in 6 worldwide, experience infertility, highlighting the urgent need to improve access to affordable, high-quality fertility care for those in need during April 2023 (Source: WHO). While the WHO previously estimated (in 2010) that 48.5 million people worldwide were affected by infertility, current estimates (2023) suggest that up to 186 million individuals worldwide may be impacted. Nonetheless, there are geographical differences in the cause and prevalence of infertility, as well as restricted access to ART. Untreated sexually transmitted infections, post-abortion, and postpartum infections are the main reasons for the high prevalence of infertility in Sub-Saharan Africa.

RESTRAINT: Social and ethical concerns in developing countries

While governments in some countries depend on government advice, others have established a legislative framework to address legal concerns related to reproductive treatment. The regulations of fertility treatments vary widely from country to country; those that are permissible in one can be entirely prohibited in another. In less developed countries, IVF treatment has raised ethical and social issues. These conditions, like access issues precipitated by cost, foster inequality. Religious and cultural perspectives may enhance ethical issues in the use of donor gametes, spare embryos, and embryo choice.

 

OPPORTUNITY: Growth Opportunities in Emerging Economies

There are a number of reasons why the medical tourism industry is thriving in developing countries. Most doctors and surgeons in Asia have their training and education at top-level institutions in Europe and the US, and medical facilities are of high standard and treatment procedures are reasonably affordable.

Brazil boasts over 20 medical facilities and around 150 facilities offering infertility treatment. In the US, an IVF cycle will cost around $12,000, whereas in Brazil, the same can be completed for around $4,000. India is among the cheapest places in the world to have IVF and other infertility treatments, with more than 500 individual IVF centers. In the US, a cycle of IVF will cost around $12,000, but in India, the same can be completed for between $2,000 and $3,000.

CHALLENGES: Reduced efficacy of infertility treatments for patients of advanced age

More and more older women are now seeking the help of infertility clinics due to the changing social environment. It will take women longer to get pregnant with increasing age, and the likelihood of not getting pregnant also increases. Moreover, as mothers increase in age, so do the issues during pregnancy and labor. 35 years or above is generally considered to be advanced maternal age. With increasing age, individuals often suffer from a decline in fertility, which may restrict their ability to become pregnant. Pregnant women whose partners are 45 years or older are 28% more likely to develop gestational diabetes, as per research. Premature birth, low blood sugar at birth, bigger babies, and a greater risk of developing type 2 diabetes as an adult are all outcomes of this.

Global Assisted Reproductive Technology Market Ecosystem Analysis

The ecosystem of the assisted reproductive technology market comprises elements present in this market and defines these elements with a demonstration of the bodies involved. It includes manufacturers, distributors, research & product developers, and end users.

Manufacturers include organizations involved in research, design, product development, optimization, and launch. Distributors include third parties and e-commerce sites linked to the organization for the marketing of medical devices. Research & product developers include in-house research facilities, contract research organizations, and contract development & manufacturing organizations, which play an important role in outsourcing research for product development. End users include patients who use assisted reproductive technology. On the other hand, investors/funders and health regulatory bodies are the major influencers in this market.

Assisted Reproductive Technology Market Ecosystem
 

The IVF segment to grow with highest CAGR in the forecast period, by technology

Owing to constant technological advancements, increasing rates of infertility, and greater awareness about fertility treatments, the in-vitro fertilization (IVF) segment is expected to register the highest CAGR during the forecast period in the ART market. Time-lapse imaging, artificial intelligence-based embryo selection, and improved cryopreservation techniques are a few of the technologies that are boosting IVF success rates and making it the preferred treatment for patients. The sector is also expanding due to drivers such as delayed childbearing, reproductive issues associated with lifestyle factors, and increasing government support for ART treatments.

The media segment to grow with highest CAGR in the forecast period, by type

As a result of the increasing need for high-end culture media, sperm-washing media, and cryopreservation media utilized in assisted reproductive treatments, the media segment is expected to grow at the highest CAGR in the ART market during the forecast period. Advances in media formulations, including embryo culture media supplemented with growth factors and antioxidants, are dramatically enhancing embryo survivability and implantation rates. Since greater emphasis is being placed on maximizing in-vitro environments for embryo development and maximizing ART success rates, the demand for innovative media solutions will be greater in the next few years.

The Asia Pacific region is projected to register the highest growth rate during the forecast period.

The Asia Pacific market is expected to witness the highest compound annual growth rate (CAGR) of the ART market over the forecast period because of the growing incidence of infertility, greater awareness about fertility treatments, and the availability of reproductive technologies. The market is witnessing growth in medical tourism because countries such as Malaysia, Thailand, and India offer high-quality but affordable ART treatment. The market is also expanding due to rising fertility clinics, improving healthcare infrastructure, and promotion of government initiatives such as ART procedure subsidization and regulatory approvals. Additionally, advancements in genetic screening and cryopreservation technologies will continue to drive the ART market's explosive growth in Asia Pacific.

CHINA FASTEST-GROWING MARKET IN THE REGION
ASIA PACIFIC FASTEST GROWING MARKET IN THE REGION
Assisted Reproductive Technology Market Region

Recent Developments of Assisted Reproductive Technology Market

  • In January 2025, FUJIFILM Irvine Scientific agreed to sell its Medical Media Business Unit (MBU) to Astorg, aligning with its focus on life sciences. This divestiture enables the company to strengthen its core offerings in innovative and accessible therapies.
  • In May 2024, Vitrolife acquired eFertility to enhance standardization and digitalization in IVF clinics globally.
  • In June 2024, CooperSurgical Inc. acquired ZyMot Fertility, a subsidiary of DxNow, Inc. The sperm separation device of ZyMot Fertility will add to the CooperSurgical Inc. portfolio of ART products and services.
  • In May 2023, Genea BIOMEDX and AIVF partnered to create a suite of AI-based solutions to enhance the efficiency and success rates of IVF clinics

Key Market Players

KEY PLAYERS IN THE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET INCLUDE

Want to explore hidden markets that can drive new revenue in Assisted Reproductive Technology Market?

Scope of the Report

Report Metric Details
Market size available for years 2022-2030
Base Year Considered 2024
Forecast period 2025-2030
Forecast units Value (USD Million)
Segments covered By Technology, Type, Patient Type, Care Setting and Region
Geographies covered North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa

 

Key Questions Addressed by the Report

Who are the leading industry players in the assisted reproductive technology market?
The key players in this market are CooperSurgical Inc. (US), FUJIFILM Irvine Scientific (Japan), Vitrolife (Sweden), Hamilton Thorne (US), and Cook Medical Inc. (US).
Which technology segments have been included in the assisted reproductive technology market report?
The report includes the following technology segments: IVF and Artificial Insemination.
Which region dominated the assisted reproductive technology market in 2024?
In 2024, the Asia Pacific region accounted for the largest share of the assisted reproductive technology market.
What are the emerging trends in the assisted reproductive technology market?
Key trends include the integration of AI and machine learning for embryo selection and success rate prediction, the growing popularity of fertility preservation (egg and sperm freezing), and the rise of medical tourism for affordable reproductive treatments in countries like Spain, Thailand, and India.
What is the total CAGR expected for the assisted reproductive technology market during 2025−2030?
The assisted reproductive technology market is expected to grow at a CAGR of 7.0% during the forecast period.

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Assisted Reproductive Technology Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
1
RESEARCH METHODOLOGY
15
EXECUTIVE SUMMARY
45
PREMIUM INSIGHTS
71
MARKET OVERVIEW
96
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    RESTRAINTS
    OPPORTUNITIES
    CHALLENGES
  • 5.3 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - TIME-LAPSE TECHNOLOGY
    COMPLEMENTARY TECHNOLOGIES
    - PREIMPLANTATION GENETIC TESTING
    ADJACENT TECHNOLOGIES
    - SPERM CRYOPRESERVATION
  • 5.4 INDUSTRY TRENDS
  • 5.5 SUPPLY CHAIN ANALYSIS
  • 5.6 TRADE ANALYSIS
  • 5.7 PORTER'S FIVE FORCE ANALYSIS
  • 5.8 REGULATORY LANDSCAPE
    REGULATORY ANALYSIS
    REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATION
  • 5.9 PATENT ANALYSIS
  • 5.10 PRICING ANALYSIS
    AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY TYPE
    AVERAGE SELLING PRICE TREND, BY REGION
  • 5.11 KEY CONFERENCES & EVENTS DURING 2025-2026
  • 5.12 KEY STAKEHOLDERS & BUYING CRITERIA
    KEY STAKEHOLDERS & BUYING PROCESS
    BUYING CRITERIA
  • 5.13 ECOSYSTEM/MARKET MAP
  • 5.14 ADJACENT MARKET ANALYSIS
  • 5.15 CASE STUDY ANALYSIS
  • 5.16 IMPACT OF AI/GEN ON ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET
  • 5.17 UNMET NEEDS/END USER EXPECTATIONS IN ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET
  • 5.18 VALUE CHAIN ANALYSIS
  • 5.19 TRENDS/DISRUPTION IMPACTING CUSTOMER’S BUSINESS
  • 5.20 INVESTMENT AND FUNDING SCENARIO
ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION)
115
  • 6.1 INTRODUCTION
  • 6.2 IN-VITRO FERTILIZATION (IVF)
    IVF WITH INTRACYTOPLASMIC SPERM INJECTION (ICSI)
    IVF WITHOUT INTRACYTOPLASMIC SPERM INJECTION (ICSI)
  • 6.3 ARTIFICIAL INSEMINATION
ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET, BY TYPE, 2022-2030 (USD MILLION)
146
  • 7.1 INTRODUCTION
  • 7.2 INSTRUMENTS
    EMBRYO INCUBATORS
    MICROMANIPULATORS (FOR ICSI)
    SPERM ANALYZER SYSTEMS
    OTHERS
  • 7.3 MEDIA
    CRYOPRESERVATION MEDIA
    OVUM PROCESSING MEDIA
    EMBRYO CULTURE MEDIA
    SEMEN PROCESSING MEDIA
  • 7.4 SUPPLEMENTS
  • 7.5 CONSUMABLES
    CULTURE DISHES AND PLATES
    STORAGE CONTAINERS
    CRYO-VIALS AND TUBES
    OTHERS
ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET, BY PATIENT TYPE, 2022-2030 (USD MILLION)
183
  • 8.1 INTRODUCTION
  • 8.2 MALE
  • 8.3 FEMALE
ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET, BY END USER, 2022-2030 (USD MILLION)
192
  • 9.1 INTRODUCTION
  • 9.2 FERTILITY CLINICS
  • 9.3 HOSPITALS & SURERY CLINICS
  • 9.4 CRYOBANKS
  • 9.5 RESEARCH INSTITUTE
ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET, BY COUNTRY/REGION, 2022-2030 (USD MILLION)
208
  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    US
    CANADA
  • 10.3 EUROPE
    MACROECONOMIC OUTLOOK FOR EUROPE
    GERMANY
    FRANCE
    UK
    ITALY
    SPAIN
    REST OF EUROPE
  • 10.4 ASIA PACIFIC
    MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    CHINA
    JAPAN
    INDIA
    AUSTRALIA
    SOUTH KOREA
    REST OF ASIA PACIFIC
  • 10.5 LATIN AMERICA
    MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    BRAZIL
    MEXICO
    REST OF LATIN AMERICA
  • 10.6 MIDDLE EAST & AFRICA
    MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 10.7 GCC COUNTRIES
    MACROECONOMIC OUTLOOK FOR GCC COUNTRIES
COMPETITIVE LANDSCAPE
254
  • 11.1 INTRODUCTION
  • 11.2 KEY PLAYERS STRATEGIES/RIGHT TO WIN
  • 11.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
  • 11.4 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2023
    - COMPANY FOOTPRINT
    - REGION FOOTPRINT
    - TECHNOLOGY FOOTPRINT
    - TYPE FOOTPRINT
    - PATIENT TYPE FOOTPRINT
    - END USER FOOTPRINT
  • 11.5 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SME, 2024
    - DETAILED LIST OF KEY STARTUPS/SME
    - COMPETITIVE BENCHMARKING OF KEY STARTUPS/SME
  • 11.6 BRAND/PRODUCT COMPARATIVE ANALYSIS
  • 11.7 MARKET SHARE ANALYSIS
  • 11.8 COMPETITIVE SITUATION AND TRENDS
    PRODUCT LAUNCHES & APPROVALS
    DEALS
    OTHER DEVELOPMENTS
  • 11.9 R&D ASSESSMENT OF KEY PLAYERS
  • 11.10 VALUATION AND FINANCIAL METRICS OF KEY PLAYERS IN ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET
COMPANY PROFILES
286
  • 12.1 KEY PLAYERS
    COOPERSURGICAL, INC.
    VITROLIFE
    FUJIFILM IRVINE SCIENTIFIC
    THERMO FISHER SCIENTIFIC, INC.
    COOK MEDICAL, INC
    HAMILTON THORNE LTD
    ESCO MICRO PTE. LTD.
    GENEA BIOMEDX
    LENUS PHARMA GESMBH
    KITAZATO CORPORATION
    ADVACARE PHARMA
    ZITA WEST
    VITABIOTICS LTD.
    FERTIPRO NV
    EXELTIS USA, INC.
  • 12.2 OTHER PLAYERS
    BIOIMAGER INC.
    FAIRHAVEN HEALTH
    COAST SCIENCE
    SHANGHAI UNICORN MEDICAL TECHNOLOGY CO., LTD.
    GYNEMED GMBH & CO. KG
    INVITROCARE INC.
    IVFTECH
    LABIVF ASIA PTE LTD.
    SHIVANI SCIENTIFIC
    MINITÜB GMBH
APPENDIX
293
  • 13.1 INSIGHTS OF INDUSTRY EXPERTS
  • 13.2 DISCUSSION GUIDE
  • 13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS

This research study involved the extensive use of both primary and secondary sources. It involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, the competitive landscape of market players, and key market dynamics such as drivers, opportunities, challenges, restraints, and key player strategies.

Secondary Research

This research study involved the wide use of secondary sources, directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva, white papers, and companies’ house documents. Secondary research was undertaken to identify and collect information for this extensive, technical, market-oriented, and commercial study of the assisted reproductive technology market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various supply side and demand side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, engineers, and related key executives from various companies and organizations operating in the assisted reproductive technology market. Primary sources from the demand side included hospitals, clinics, researchers, lab technicians, purchase managers etc, and stakeholders in corporate & government bodies.

A breakdown of the primary respondents for assisted reproductive technology market (supply side) market is provided below:

Assisted Reproductive Technology Market

Note 1: Companies are classified into tiers based on their total revenue. As of 2023: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million

Note 2: C-level executives include CEOs, COOs, CTOs, and VPs; other primaries include sales managers, marketing managers, and product managers.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The market size for assisted reproductive technology market was calculated using data from four different sources, as will be discussed below. Each technique concluded and a weighted average of the four ways was calculated based on the number of assumptions each approach made. The market size for assisted reproductive technology market was calculated using data from three distinct sources, as will be discussed below:

Assisted Reproductive Technology Market

Data Triangulation

The entire market was split up into three segments when the market size was determined. Data triangulation and market breakdown processes were used where necessary to complete the entire market engineering process and arrive at the precise statistics for all segments.

Approach to derive the market size and estimate market growth.

Using secondary data from both paid and unpaid sources, the market rankings for the major players were determined following a thorough analysis of their sales of assisted reproductive technology. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.

Market Definition

Assisted Reproductive Technology (ART) deals with medical procedures and techniques designed to address infertility and improve the chances of conception. ART includes all fertility treatments in which eggs or embryos are handled outside the human body. These procedures involve the use of medical technology to assist with fertilization, embryo development, and implantation.

Stakeholders

  • Infertility Treatment Device Manufacturers
  • Research Laboratories
  • Healthcare Service Providers (Hospitals, Fertility Centers, Diagnostic Centers, and Fertility Surgical Clinics)
  • Market Research and Consulting Firms
  • Medical Device Suppliers, Distributors, Channel Partners, and Third-party Suppliers
  • Infertility Associations and Organizations
  • Reproductive Endocrinologists, Andrologists, and Reproductive Surgeons
  • Academic Medical Centers and Universities
  • Business Research and Consulting Service Providers
  • Venture Capitalists and Other Government Funding Organizations

Report Objectives

  • To describe, analyze, and forecast the assisted reproductive technology market by technology, type, patient type, end user, and region
  • To describe and forecast the assisted reproductive technology market for key regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East & Africa, and the GCC Countries
  • To provide detailed information regarding the drivers, restraints, opportunities, and challenges influencing the growth of the assisted reproductive technology market
  • To strategically analyze the ecosystem, regulations, patent landscape, trade landscape, and case studies pertaining to the market under study
  • To provide a detailed overview of the supply chain pertaining to the assisted reproductive technology market ecosystem, along with the average selling prices of different types of assisted reproductive technology instruments and consumables
  • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players
  • To profile key players and comprehensively analyze their market shares and core competencies2 in the assisted reproductive technology market
  • To analyze competitive developments such as agreements, acquisitions, and product launches, in the assisted reproductive technology market
  • To analyze the ongoing trend of Al/Gen Al and provide an impact analysis

 

Previous Versions of this Report

"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.


By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Assisted Reproductive Technology Market

DMCA.com Protection Status